KANSAS CITY, Mo., Feb. 19, 2021 /PRNewswire/ -- Children's Mercy Kansas City announced the opening of its new 9-story, 375,000 square-foot, pediatric research facility located on the hospital's Adele Hall campus in the heart of downtown Kansas City. The new building is home to the Children's Mercy Research Institute® (CMRI), which was established in 2015 to accelerate precise diagnoses and treatments for complex childhood diseases and move kids to the forefront of research discoveries.
Currently only 10% of the National Institutes of Health's $37 billion annual research budget goes to support pediatric research, and only 5% of more than 7,000 rare pediatric diseases have a drug approved by the FDA.
"Pediatric research is underfunded nationally, which means kids are being left behind. This is a world-class research facility dedicated exclusively to advancing the health and well-being of children right here in Kansas City and beyond," said Paul Kempinski, MS, FACHE, President and Chief Executive Officer, Children's Mercy. "The research, innovation, and collaboration that happens inside this building will accelerate answers and give hope to families everywhere."
Ad Statistics
Times Displayed: 46852
Times Visited: 1314 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
What makes the CMRI unique is the translational approach to research. The CMRI fosters an integrated research environment where no boundaries exist between science and medicine - uniting physicians, scientists, academic colleagues and community partners working together to translate ideas and discoveries into new medicines, treatments and diagnostics.
"Every interaction at the child's bedside or in the clinic is an opportunity for our researchers and staff to learn," said Tom Curran, PhD, FRS, Senior Vice President, Executive Director and Chief Scientific Officer. "We've seamlessly integrated research with the clinical care to ensure our patients can take advantage of the latest technology and scientific advances."
The research facility has a 50/50 ratio of dry and wet lab space, a biological safety level III facility to study organisms such as COVID-19, and a specialized Good Manufacturing Practice facility to support research involving cell and gene therapy technologies.
As CMRI rapidly emerges as a leader in pediatric translational research, it has established the following Areas of Emphasis:
Genomic Medicine - The Genomic Medicine Center is one of the very few pediatric genome centers in the world carrying out clinical whole genome sequencing and single-cell genomics.
